Notably, Clausen et al. (2020) have demonstrated significantly increased risks of stroke in patients with elevated concentrations of TNFR1 and TNFR2 factors in plasma, suggesting that TNF-α level might serve as a risk factor for IS as well as the biomarker for the patient survival rate. This evidence concerns the gene TNFRSF1A and Stroke.